Načítá se...
Poor Outcomes in Elderly Kidney Transplant Recipients Receiving Alemtuzumab Induction
INTRODUCTION: Alemtuzumab and rabbit antithymocyte globulin (rATG) are being used with increasing frequency as induction agents in kidney transplantation. Using the US Renal Data Base System, we analyzed the safety profile of these agents in the elderly. METHODS: In a cohort of patients transplanted...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
S. Karger AG
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3237278/ https://ncbi.nlm.nih.gov/pubmed/22104284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000334092 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|